How Big Pharma preys on poor countries – and patients pay the price


New investigation reveals unequal access to life-saving meds across Europe thanks to system that favours the rich


This content originally appeared on openDemocracy RSS and was authored by Juliet Ferguson, Eurydice Bersi, Maxence Peigné.